NO976028L - Fremgangsmåte for kontroll av antibiotika resistente gram positive bakterier og behandling av infeksjon - Google Patents

Fremgangsmåte for kontroll av antibiotika resistente gram positive bakterier og behandling av infeksjon

Info

Publication number
NO976028L
NO976028L NO976028A NO976028A NO976028L NO 976028 L NO976028 L NO 976028L NO 976028 A NO976028 A NO 976028A NO 976028 A NO976028 A NO 976028A NO 976028 L NO976028 L NO 976028L
Authority
NO
Norway
Prior art keywords
infection
procedure
treatment
control
positive bacteria
Prior art date
Application number
NO976028A
Other languages
English (en)
Norwegian (no)
Other versions
NO976028D0 (no
Inventor
Peter Blackburn
Berth P Goldstein
Original Assignee
Ambi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambi Inc filed Critical Ambi Inc
Publication of NO976028L publication Critical patent/NO976028L/no
Publication of NO976028D0 publication Critical patent/NO976028D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
NO976028A 1995-06-23 1997-12-22 Fremgangsmåte for kontroll av antibiotika resistente gram positive bakterier og behandling av infeksjon NO976028D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43595P 1995-06-23 1995-06-23
PCT/US1996/010756 WO1997000694A1 (en) 1995-06-23 1996-06-21 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection

Publications (2)

Publication Number Publication Date
NO976028L true NO976028L (no) 1997-12-22
NO976028D0 NO976028D0 (no) 1997-12-22

Family

ID=21691527

Family Applications (1)

Application Number Title Priority Date Filing Date
NO976028A NO976028D0 (no) 1995-06-23 1997-12-22 Fremgangsmåte for kontroll av antibiotika resistente gram positive bakterier og behandling av infeksjon

Country Status (18)

Country Link
US (1) US5866539A (ja)
EP (1) EP0833657B1 (ja)
JP (1) JP4236699B2 (ja)
KR (1) KR19990028283A (ja)
CN (1) CN1138560C (ja)
AT (1) ATE247973T1 (ja)
AU (1) AU713050B2 (ja)
BR (1) BR9609281A (ja)
CA (1) CA2225530C (ja)
CZ (1) CZ290578B6 (ja)
DE (1) DE69629691T2 (ja)
ES (1) ES2201189T3 (ja)
IL (2) IL122248A0 (ja)
NO (1) NO976028D0 (ja)
NZ (1) NZ311535A (ja)
RU (1) RU2202360C2 (ja)
SK (1) SK285563B6 (ja)
WO (1) WO1997000694A1 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910479A (en) * 1996-10-18 1999-06-08 Ambi Inc. Method for the treatment of Streptococcus pneumoniae infection
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
BR0013641B1 (pt) * 1999-08-31 2009-01-13 fio dental aperfeiçoado possuindo baixa densidade e método de fabricação do mesmo.
NL1013861C2 (nl) * 1999-12-15 2001-06-18 Stichting Tech Wetenschapp Toepassing van Nisine of derivaat daarvan.
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
CA2508796A1 (en) * 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
US7517852B2 (en) 2005-07-28 2009-04-14 Biosynexus Incorporated Compositions and methods for treating bacteria
WO2007044745A1 (en) * 2005-10-11 2007-04-19 Biosynexus Incorporated Lantibiotic and mupirocin compositions for treating bacterial infections
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
US20070238652A1 (en) * 2006-02-08 2007-10-11 Biosynexus Incorporated Neutralization of bacterial spores
ITMI20060678A1 (it) * 2006-04-06 2007-10-07 Sanofi Aventis Otc S P A Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
CA2742753A1 (en) * 2008-11-24 2010-05-27 Sentinella Pharmaceuticals, Inc. ("Sentinella") Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
KR101107764B1 (ko) * 2009-01-05 2012-01-20 박세준 항 유해균 기능을 가진 에스제이피미생물
NZ594011A (en) 2009-01-14 2013-12-20 Novacta Biosystems Ltd Deoxyactagardine derivatives
JP5731407B2 (ja) 2009-02-04 2015-06-10 ノヴァクタ バイオシステムズ リミティッド アクタガルジン誘導体
US20100233669A1 (en) * 2009-03-11 2010-09-16 Cryolife, Inc. Bioburden-reducing antibiotic composition and method of use
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
US8475827B2 (en) 2010-07-06 2013-07-02 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
US8377143B2 (en) 2010-07-06 2013-02-19 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US8182842B1 (en) 2010-11-10 2012-05-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria
RU2638814C1 (ru) * 2016-09-27 2017-12-15 Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации Способ профилактики инфекционных осложнений бактериальной природы после операции на сердце, проведенной в условиях искусственного кровообращения
CN108982430B (zh) * 2017-05-31 2020-09-29 北京大学 标记细菌菌群样品的试剂盒、方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931390A (en) * 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5217950A (en) * 1988-06-22 1993-06-08 Applied Microbiology, Inc. Nisin compositions for use as enhanced, broad range bactericides
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions

Also Published As

Publication number Publication date
BR9609281A (pt) 1999-06-15
IL122248A0 (en) 1998-04-05
CN1188415A (zh) 1998-07-22
AU6289196A (en) 1997-01-22
IL122248A (en) 2009-09-01
RU2202360C2 (ru) 2003-04-20
US5866539A (en) 1999-02-02
KR19990028283A (ko) 1999-04-15
DE69629691D1 (de) 2003-10-02
CN1138560C (zh) 2004-02-18
AU713050B2 (en) 1999-11-25
WO1997000694A1 (en) 1997-01-09
SK285563B6 (sk) 2007-03-01
CZ290578B6 (cs) 2002-08-14
EP0833657B1 (en) 2003-08-27
EP0833657A1 (en) 1998-04-08
JPH11508265A (ja) 1999-07-21
ATE247973T1 (de) 2003-09-15
JP4236699B2 (ja) 2009-03-11
SK172697A3 (en) 1998-12-02
CZ402597A3 (cs) 1998-09-16
CA2225530A1 (en) 1997-01-09
ES2201189T3 (es) 2004-03-16
NZ311535A (en) 2001-05-25
DE69629691T2 (de) 2004-02-26
NO976028D0 (no) 1997-12-22
CA2225530C (en) 2002-08-20

Similar Documents

Publication Publication Date Title
NO976028D0 (no) Fremgangsmåte for kontroll av antibiotika resistente gram positive bakterier og behandling av infeksjon
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
DK0817797T3 (da) Glycopeptidantibiotikumderivater
BR9913225A (pt) Novos agentes antibacterianos de isoxazolinona
GB0026924D0 (en) Antibacterial agents
EP1037650A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS
DE69631381T2 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
EP2250887A3 (en) Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins
DE69827814D1 (de) 8a-AZALIDEN ALS ANTIMIKROBIELLE AGENTEN
GB2377638B (en) Treatment of infection in animals
NO991827L (no) FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon
DK120892D0 (da) Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
HUP9901183A2 (hu) Készítmények és eljárások az orális mukozitisz megakadályozására és kezelésére
RU96104662A (ru) Штамм бактерий bacillus subtilis, используемый для обеззараживания птичьего помета и навоза от патогенных микроорганизмов
EP1779853A3 (en) 9a-azalides as veterinary antimicrobial agents
ES2076107A1 (es) Derivados de antibioticos macrolidos de anillos de 16 miembros.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application